We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PET Imaging Could Aid in Predicting Alzheimer's Disease Progression

By HospiMedica International staff writers
Posted on 09 Aug 2010
Recent research suggests that specific brain scans combined with memory tests could indicate whether people with mild cognitive impairment (MCI) will go on to develop Alzheimer's disease. More...


The study, compiled by Dr. Susanne Sorensen, head of research, and investigators from the UK Alzheimer's Society (London), revealed that individuals who showed abnormal results on a positron emission tomography (PET) imaging brain scan, which detects metabolic abnormalities and episodic memory tests, were nearly 12 times more apt to develop Alzheimer's disease.

The spokespersons for the Alzheimer's Society commented, "We don't currently know which people with MCI will go on to develop Alzheimer's disease. This important study moves us a step closer to unraveling this mystery. The tests identified could have real benefits in our search for a cause or cure for the disease, helping researchers identify suitable participants for drug trials. At this stage, it is a leap too far to say these tests can have immediate benefits for routine diagnosis. They are currently too expensive and the prognosis of Alzheimer's they provide is not 100% guaranteed. We need more investment into research and treatment if we are to move our knowledge forward and improve the lives of people with dementia.”

The study was published online in July 2010 in the journal Neurology.

Related Links:

Alzheimer's Society




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.